PeerVoice Oncology & Haematology Audio-logo

PeerVoice Oncology & Haematology Audio

Education Podcasts

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

Location:

United States

Description:

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

Language:

English

Episodes

Defining a Patient-Centred Approach to Non-Metastatic Castration-Resistant Prostate Cancer

7/1/2020
Defining a Patient-Centred Approach to Non-Metastatic Castration-Resistant Prostate Cancer

Duration:01:19:29

Treatment Update in CML: What’s New, and What Does it Mean for Patients?

6/26/2020
Treatment Update in CML: What’s New, and What Does it Mean for Patients?

Duration:00:20:47

"Case Studies in Locally Advanced and Metastatic CSCC: Integrating Immunotherapy Into Current Treatment Paradigms"

6/22/2020
"Case Studies in Locally Advanced and Metastatic CSCC: Integrating Immunotherapy Into Current Treatment Paradigms"

Duration:00:20:11

Hiding in Plain Sight: Identifying Patients at Risk for NASH

6/19/2020
Hiding in Plain Sight: Identifying Patients at Risk for NASH

Duration:00:24:33

Practical Lessons From Real-World Evidence on CDK 4/6 Inhibitors in Metastatic Breast Cancer

5/18/2020
Practical Lessons From Real-World Evidence on CDK 4/6 Inhibitors in Metastatic Breast Cancer

Duration:00:22:00

Changing Strategies for Changing Times: Optimising Use of Targeted Alpha Therapies for Advanced Prostate Cancer

5/13/2020
Changing Strategies for Changing Times: Optimising Use of Targeted Alpha Therapies for Advanced Prostate Cancer

Duration:00:23:31

Raising the Caliber of Non-Metastatic CRPC Care: Introducing Quality of Life Into the Equation

5/8/2020
Raising the Caliber of Non-Metastatic CRPC Care: Introducing Quality of Life Into the Equation

Duration:00:37:41

Evolving the Treatment Paradigm in HER2-Positive Breast Cancer: Are New Options on the Horizon?

2/21/2020
Evolving the Treatment Paradigm in HER2-Positive Breast Cancer: Are New Options on the Horizon?

Duration:00:15:21

The Evolving Landscape in Advanced CTCL: Can Emerging Therapies Enhance Patient Management?

1/15/2020
The Evolving Landscape in Advanced CTCL: Can Emerging Therapies Enhance Patient Management?

Duration:00:22:57

Sequencing Therapy in mRCC: How Does an Evolving Treatment Pathway Change Decisions?

1/13/2020
Sequencing Therapy in mRCC: How Does an Evolving Treatment Pathway Change Decisions?

Duration:00:16:05

Evolution of Paroxysmal Nocturnal Haemoglobinuria: Complementing Current Approaches to Management

12/27/2019
Evolution of Paroxysmal Nocturnal Haemoglobinuria: Complementing Current Approaches to Management

Duration:00:30:24

Immuno-oncology for mRCC: Considerations for a Combination Approach in the First-Line Setting

12/4/2019
Immuno-oncology for mRCC: Considerations for a Combination Approach in the First-Line Setting

Duration:00:18:33

Recognising and Addressing Burden of Disease in Adolescents With Moderate-to-Severe AD

12/2/2019
Recognising and Addressing Burden of Disease in Adolescents With Moderate-to-Severe AD

Duration:00:19:32

Heading Toward a More Successful Approach to Migraine Management

11/27/2019
Heading Toward a More Successful Approach to Migraine Management

Duration:00:13:39

Choose Your Own HS Adventure: Going Beyond Current Guidelines

11/15/2019
Choose Your Own HS Adventure: Going Beyond Current Guidelines

Duration:00:57:28

Warming Up to Novel Approaches for Primary Cold Agglutinin Disease: Strategies for Correct Diagnosis and Optimal Treatment

11/4/2019
Warming Up to Novel Approaches for Primary Cold Agglutinin Disease: Strategies for Correct Diagnosis and Optimal Treatment

Duration:00:16:07

PARP Inhibitors for Ovarian Cancer: Making the Right Choices at the Right Times

10/30/2019
PARP Inhibitors for Ovarian Cancer: Making the Right Choices at the Right Times

Duration:00:09:51

Paving the Way to Better Outcomes in EGFR-Mutant NSCLC: Time to Take a Step Further?

10/16/2019
Paving the Way to Better Outcomes in EGFR-Mutant NSCLC: Time to Take a Step Further?

Duration:01:07:35

Maximising the Long-Term Treatment Plan for Unresectable Hepatocellular Carcinoma: A Sequential Approach to Improving Patient Outcomes

7/8/2019
Maximising the Long-Term Treatment Plan for Unresectable Hepatocellular Carcinoma: A Sequential Approach to Improving Patient Outcomes

Duration:00:20:46

The Power of Personalised Medicine: CAR-T Immunotherapy for Treatment of Aggressive Large B-Cell Lymphoma

7/5/2019
The Power of Personalised Medicine: CAR-T Immunotherapy for Treatment of Aggressive Large B-Cell Lymphoma

Duration:00:21:50

See More